Biogelx Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Out of Business

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Liquidation

  • Investors
  • 1

Biogelx General Information

Description

Developer of tuneable peptide hydrogels and bio-inks designed to be used in the fields of 3D cell culture and bioprinting. The company's products are used for applications in cell culture research, cell-based toxicity screening, cancer cell research, animal testing, and other therapeutic applications which can ultimately be translated to cell therapy and regenerative medicine, enabling academic users, medical researchers, and pharmaceutical companies to study and manipulate cells in a realistic 3D environment.

Contact Information

Website
www.biogelx.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • BioCity Scotland, Bo'Ness Road
  • Newhouse
  • Lanark ML1 5UH
  • Scotland, United Kingdom
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Specialty Chemicals
Vertical(s)
Corporate Office
  • BioCity Scotland, Bo'Ness Road
  • Newhouse
  • Lanark ML1 5UH
  • Scotland, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biogelx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Bankruptcy: Liquidation 29-Sep-2021 Completed Bankruptcy: Liquidation
7. Grant 01-May-2017 Completed Generating Revenue
6. Grant 18-Apr-2017 Completed Generating Revenue
5. Early Stage VC 30-Mar-2017 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2016 Completed Generating Revenue
3. Early Stage VC 17-Jun-2015 Completed Generating Revenue
2. Early Stage VC 18-Dec-2012 $257K $257K Completed Generating Revenue
1. University Spin-Out 01-Jan-2012 Completed Startup
To view Biogelx’s complete valuation and funding history, request access »

Biogelx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 4,803 $0.012342 $12.84 $12.84 1x $12.84 3.1%
Ordinary 29,950 $0.012342 $2.47 $2.47 1x $2.47 19.3%
To view Biogelx’s complete cap table history, request access »

Biogelx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of tuneable peptide hydrogels and bio-inks designed to be used in the fields of 3D cell culture and bioprintin
Other Pharmaceuticals and Biotechnology
Lanark, United Kingdom
12 As of 2020

Mont-Saint-Guibert, Belgium
 

Aliso Viejo, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biogelx Competitors (4)

One of Biogelx’s 4 competitors is Cellaion, a Formerly VC-backed company based in Mont-Saint-Guibert, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cellaion Formerly VC-backed Mont-Saint-Guibert, Belgium
Ambry Genetics Formerly PE-Backed Aliso Viejo, CA
Xenetic Biosciences Corporation Framingham, MA
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
To view Biogelx’s complete competitors history, request access »

Biogelx Patents

Biogelx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201716850-D0 Improved 3d printing and drug delivery Inactive 13-Oct-2017
GB-201716852-D0 Improved 3d printing and drug delivery Inactive 13-Oct-2017
AU-2017371444-A1 3d printing and drug delivery Inactive 09-Dec-2016
EP-3551240-A1 3d printing and drug delivery Inactive 09-Dec-2016
US-20190321291-A1 3d printing and drug delivery Inactive 09-Dec-2016 C07K5/06121
To view Biogelx’s complete patent history, request access »

Biogelx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biogelx Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
The University of Strathclyde University
To view Biogelx’s complete investors history, request access »

Biogelx FAQs

  • When was Biogelx founded?

    Biogelx was founded in 2012.

  • Where is Biogelx headquartered?

    Biogelx is headquartered in Lanark, United Kingdom.

  • What is the size of Biogelx?

    Biogelx has 12 total employees.

  • What industry is Biogelx in?

    Biogelx’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Biogelx a private or public company?

    Biogelx is a Private company.

  • What is Biogelx’s current revenue?

    The current revenue for Biogelx is .

  • How much funding has Biogelx raised over time?

    Biogelx has raised $1.44M.

  • Who are Biogelx’s investors?

    The University of Strathclyde has invested in Biogelx.

  • Who are Biogelx’s competitors?

    Cellaion, Ambry Genetics, Xenetic Biosciences, and Genetix Biotherapeutics are competitors of Biogelx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process